ITEM 3.02
UNREGISTERED SALES OF EQUITY SECURITIES
On October 25, 2016, Arvana Inc. (“Company”) entered into Settlement Agreement and Release with
Jeffrey and Vivienne Lawrence, dated effective September 30, 2016, in connection with satisfying a debt
in the amount of $74,450, comprised of a loan and accrued interest, in exchange for 148,900 shares of the
Company’s common stock valued at $0.50 per share, pursuant to the exemptions from registration
provided under Section 4(2) and Regulation S of the Securities Act of 1933, as amended (“Securities
Act”). No commissions or fees were paid in connection with this offering.
The Company complied with the exemption requirements of Section 4(2) of the Securities Act based on
the following factors: (1) the issuance was an isolated private transaction that did not involve a public
offering; (2) there were only two offerees who were issued shares in exchange for the settlement of debt;
(3) the offerees committed to hold their stock; (4) there have been no subsequent or contemporaneous
public offerings of the stock; (5) the stock has not been broken down into smaller denominations; and (6)
the discussions that led to the debt settlement took place directly between the offerees and the Company.
The Company complied with the requirements of Regulation S of the Securities Act by having directed no
offering efforts in the United States, by offering common shares only to offerees who were outside of the
United States at the time of the offering, and ensuring that the offerees to whom the securities were
offered were non-U.S. offerees with an address in a foreign country.
http://www.otcmarkets.com/edgar/GetFilingHtml?FilingID=11663607
Recent AVNI News
- Form SC 13G - Statement of acquisition of beneficial ownership by individuals • Edgar (US Regulatory) • 02/26/2024 07:41:12 PM
- Form SC 13G - Statement of acquisition of beneficial ownership by individuals • Edgar (US Regulatory) • 02/21/2024 10:18:44 PM
- Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend] • Edgar (US Regulatory) • 02/15/2024 03:28:19 PM
- Form SC 13G - Statement of acquisition of beneficial ownership by individuals • Edgar (US Regulatory) • 02/15/2024 03:27:18 PM
- Form SC 13G - Statement of acquisition of beneficial ownership by individuals • Edgar (US Regulatory) • 02/14/2024 08:24:46 PM
- Form SC 13G - Statement of acquisition of beneficial ownership by individuals • Edgar (US Regulatory) • 02/14/2024 08:01:17 PM
- Form 4/A - Statement of changes in beneficial ownership of securities: [Amend] • Edgar (US Regulatory) • 01/31/2024 01:53:15 AM
- Form 10-Q - Quarterly report [Sections 13 or 15(d)] • Edgar (US Regulatory) • 11/14/2023 08:58:37 PM
- Form 10-Q - Quarterly report [Sections 13 or 15(d)] • Edgar (US Regulatory) • 08/17/2023 07:38:36 PM
- Form NT 10-Q - Notification of inability to timely file Form 10-Q or 10-QSB • Edgar (US Regulatory) • 08/14/2023 07:59:03 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 07/07/2023 09:17:09 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 06/29/2023 05:02:13 PM
NanoViricides Reports that the Phase I NV-387 Clinical Trial is Completed Successfully and Data Lock is Expected Soon • NNVC • May 2, 2024 10:07 AM
ILUS Files Form 10-K and Provides Shareholder Update • ILUS • May 2, 2024 8:52 AM
Avant Technologies Names New CEO Following Acquisition of Healthcare Technology and Data Integration Firm • AVAI • May 2, 2024 8:00 AM
Bantec Engaged in a Letter of Intent to Acquire a Small New Jersey Based Manufacturing Company • BANT • May 1, 2024 10:00 AM
Cannabix Technologies to Deliver Breath Logix Alcohol Screening Device to Australia • BLO • Apr 30, 2024 8:53 AM
Hydromer, Inc. Reports Preliminary Unaudited Financial Results for First Quarter 2024 • HYDI • Apr 29, 2024 9:10 AM